MenoTIDE PLUS: A European study for the relief of menopause symptoms.
The research was conducted in 2017 by certified specialists from the Regenerative Medicine and Nutritional Medicine Department of the European Scientific Society at the Academy of Natural Sciences (Hanover).
A study was conducted to evaluate the effectiveness of the multi-component bioregulator "MenoTIDE PLUS" with peptides, intended for women during menopause. The study involved randomly selected patients who consulted a physician specializing in regenerative medicine, proficient in and applying functional diagnostics, laser therapy, acupuncture, and bioresonance therapy.
Bioregulators were selected based on tests conducted using the KME apparatus, employing a survey method. The study involved 15 patients – women aged 50-65 diagnosed with stage 1 and 2 menopausal syndrome. The main complaints of the patients studied were: dizziness, frequent mood swings, increased blood pressure, night sweats and hot flashes, and vaginal dryness.
Patients were prescribed the multicomponent bioregulator "MenoTIDE PLUS" at a dosage of 1 or 2 capsules per day for 30 days, depending on the severity of their condition. After taking the "MenoTIDE PLUS" bioregulator, and in some patients even after 5-7 days from the start of treatment, a significant improvement in menopausal symptoms was observed: mood improved, blood pressure stabilized, sweating and hot flashes decreased or disappeared altogether. None of the patients studied who used the multicomponent peptide bioregulator...
No side effects, complications, or drug dependence were observed with "MenoTIDE PLUS".
Source of information: https://myrealway.com/menotide-plus-peptides-for-menopause
